Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
Clinical trial NCT04115163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04115163
- Sponsor
- Anne Noonan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2026-12-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.